Macrophages to Enhance Recovery of Skeletal Muscle following Disuse Atrophy in Aging

巨噬细胞可增强衰老废用性萎缩后骨骼肌的恢复

基本信息

  • 批准号:
    9395538
  • 负责人:
  • 金额:
    $ 5.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Older adults are at risk to be injured, ill, and hospitalized resulting in physical inactivity-induced muscle atrophy and weakness. Moreover, older adults have an impaired muscle recovery following disuse. Therefore, there exists a need to further understand the cellular mechanisms behind this impaired muscle regrowth with aging. Macrophages are of vital importance during the muscle regrowth following disuse atrophy, however, their role under such conditions in aging skeletal muscle has surprisingly not been previously elucidated. Therefore, using a mouse model of disuse atrophy and regrowth of skeletal muscle, Dr. Reidy and mentoring team have compiled convincing preliminary data demonstrating an impaired muscle regrowth in aging mice and this is accompanied by a blunted macrophage immune response (recruitment and activation of muscle macrophages) in skeletal muscle during muscle recovery. Therefore, I have proposed to conduct an extensive time course of the muscle macrophage response in old and young mice during recovery from disuse (Aim 1) in order to reveal key time points for novel therapeutic intervention. Macrophage immunotherapy and immunomodulation has been successful to improve muscle recovery following ischemia-reperfusion injury and recovery from disuse in young mice. Given the impaired regrowth in aging skeletal muscle and the potential impact of macrophage therapy the goal of Aim 2 is to use macrophage immunotherapy and immunomodulation to restore the regrowth in aging skeletal muscle following disuse. My preliminary data suggested that aging skeletal muscle has impaired macrophage recruitment, and further supported by a decrease in the mRNA expression, of a pivotal chemotactic factor, chemokine (C-C motif) ligand 2 (CCL2). As a follow-up to Aim 2, we will determine if inhibiting macrophage recruitment (CCL2 KO mice) will result in a phenotype characteristic of old mice during recovery from disuse. We plan to use this data to develop a career development award for follow-up mechanistic and parallel human experiments. Additionally, the research project during this fellowship will be tied with various training experiences including new skill acquisition and exposure to aging and metabolism seminars, grant workshops, and interdisciplinary interactions.
项目摘要/摘要 老年人有受伤,病和住院的风险,导致身体不活跃 肌肉萎缩和无力。此外,老年人的肌肉恢复受损 废弃后。因此,有必要进一步了解细胞机制 随着衰老而受损的肌肉再生。巨噬细胞至关重要 然而,废除萎缩后的肌肉再生,它们在这种情况下在衰老中的作用 骨骼肌以前尚未阐明。因此,使用鼠标 Reidy博士和指导团队的骨骼肌萎缩和再生模型 编译令人信服的初步数据,证明了衰老小鼠的肌肉再生受损 这伴随着巨大的巨噬细胞免疫反应(招募和 肌肉恢复过程中骨骼肌的肌肉巨噬细胞的激活。因此,我 提议在旧的肌肉巨噬细胞反应中进行广泛的时间过程 和年轻的老鼠从废弃(AIM 1)中恢复(AIM 1),以揭示新颖的关键时间点 治疗干预。巨噬细胞免疫疗法和免疫调节已经 在缺血 - 再灌注损伤和从 在年轻老鼠中废弃。鉴于老化骨骼肌的再生和潜力受损 巨噬细胞疗法的影响目标2是使用巨噬细胞免疫疗法和 免疫调节以恢复废弃后老化骨骼肌的再生。我的 初步数据表明,衰老的骨骼肌损害了巨噬细胞的募集, 并进一步支持mRNA表达的降低,关键趋化因子的mRNA表达, 趋化因子(C-C基序)配体2(CCL2)。作为AIM 2的后续行动,我们将确定是否抑制 巨噬细胞募集(CCL2 KO小鼠)将导致旧小鼠的表型 在恢复废弃期间。我们计划使用这些数据开发职业发展奖 用于后续机械和平行的人类实验。此外,研究项目 在此奖学金期间,将与包括新技能获取在内的各种培训经验并列 以及接触衰老和代谢研讨会,授予研讨会和跨学科 互动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

相似国自然基金

温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
  • 批准号:
    12302265
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
  • 批准号:
    52308322
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
  • 批准号:
    52373051
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
  • 批准号:
    42377282
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
  • 批准号:
    52376132
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Promoting regenerative repair of aged cartilage
促进老化软骨的再生修复
  • 批准号:
    10660184
    10660184
  • 财政年份:
    2023
  • 资助金额:
    $ 5.67万
    $ 5.67万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 5.67万
    $ 5.67万
  • 项目类别:
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial
大麻二酚对有阿尔茨海默病风险的个体来说:一项随机安慰剂对照试验
  • 批准号:
    10677333
    10677333
  • 财政年份:
    2023
  • 资助金额:
    $ 5.67万
    $ 5.67万
  • 项目类别:
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
一项饮食干预研究,旨在减轻患有急性后 COVID-19 综合症的老年人的疲劳症状并改善肌肉和身体功能
  • 批准号:
    10734981
    10734981
  • 财政年份:
    2023
  • 资助金额:
    $ 5.67万
    $ 5.67万
  • 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
  • 批准号:
    10809199
    10809199
  • 财政年份:
    2023
  • 资助金额:
    $ 5.67万
    $ 5.67万
  • 项目类别: